Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

NR4A3 Immunohistochemistry Lacks Sensitivity for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.

Vargas AC, Maclean FM, Bonar F, Mahar A, Gill AJ.

Am J Surg Pathol. 2019 Aug 12. doi: 10.1097/PAS.0000000000001346. [Epub ahead of print] No abstract available.

PMID:
31414988
2.

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.

Vennin C, Mélénec P, Rouet R, Nobis M, Cazet AS, Murphy KJ, Herrmann D, Reed DA, Lucas MC, Warren SC, Elgundi Z, Pinese M, Kalna G, Roden D, Samuel M, Zaratzian A, Grey ST, Da Silva A, Leung W; Australian Pancreatic Genome Initiative (APGI), Mathivanan S, Wang Y, Braithwaite AW, Christ D, Benda A, Parkin A, Phillips PA, Whitelock JM, Gill AJ, Sansom OJ, Croucher DR, Parker BL, Pajic M, Morton JP, Cox TR, Timpson P.

Nat Commun. 2019 Aug 12;10(1):3637. doi: 10.1038/s41467-019-10968-6.

3.

Loss of nuclear localization of thyroid transcription factor 1 and adverse outcomes in papillary thyroid Cancer.

Lopez-Campistrous A, Theissen A, Gill AJ, Ghosh S, McMullen TP.

Hum Pathol. 2019 Jun 20. pii: S0046-8177(19)30110-8. doi: 10.1016/j.humpath.2019.06.002. [Epub ahead of print]

PMID:
31229486
4.

Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.

Morrow A, Hogden E, Kang YJ, Steinberg J, Canfell K, Solomon MJ, Kench JG, Gill AJ, Shaw T, Pachter N, Parkinson B, Wolfenden L, Mitchell G, Macrae F, Tucker K, Taylor N.

Trials. 2019 Jun 20;20(1):373. doi: 10.1186/s13063-019-3457-6.

5.

Novel Prognostic Markers in Triple-Negative Breast Cancer Discovered by MALDI-Mass Spectrometry Imaging.

Phillips L, Gill AJ, Baxter RC.

Front Oncol. 2019 May 14;9:379. doi: 10.3389/fonc.2019.00379. eCollection 2019.

6.

SMARCA4 Loss Is Very Rare in Thoracic Mesothelioma.

Ahadi MS, Gill AJ.

Am J Surg Pathol. 2019 Aug;43(8):1154-1155. doi: 10.1097/PAS.0000000000001262. No abstract available.

PMID:
31021854
7.

High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex.

Trpkov K, Bonert M, Gao Y, Kapoor A, He H, Yilmaz A, Gill AJ, Williamson SR, Comperat E, Tretiakova M, Magi-Galluzzi C, Brimo F, Hes O.

Histopathology. 2019 Sep;75(3):440-442. doi: 10.1111/his.13876. Epub 2019 Jul 2. No abstract available.

PMID:
31002177
8.

RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma.

Joo LJS, Weiss J, Gill AJ, Clifton-Bligh R, Brahmbhatt H, MacDiarmid JA, Gild ML, Robinson BG, Zhao JT, Sidhu SB.

Thyroid. 2019 Jun;29(6):830-844. doi: 10.1089/thy.2018.0525. Epub 2019 May 9.

PMID:
30929576
9.

microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.

Kwok GTY, Zhao JT, Glover AR, Gill AJ, Clifton-Bligh R, Robinson BG, Ip JCY, Sidhu SB.

Oncologist. 2019 Jun;24(6):e241-e250. doi: 10.1634/theoncologist.2018-0849. Epub 2019 Mar 27.

PMID:
30918109
10.

Australasian Gastrointestinal Pathology Society (AGPS) consensus guidelines for universal defective mismatch repair testing in colorectal carcinoma.

Yozu M, Kumarasinghe MP, Brown IS, Gill AJ, Rosty C.

Pathology. 2019 Apr;51(3):233-239. doi: 10.1016/j.pathol.2018.11.014. Epub 2019 Mar 6.

PMID:
30851981
11.

Androgen receptor immunoexpression in triple-negative breast cancers: is it a prognostic factor?

Zaborowski M, Pearson A, Sioson L, Gill AJ, Ahadi MS.

Pathology. 2019 Apr;51(3):327-329. doi: 10.1016/j.pathol.2018.09.063. Epub 2019 Mar 5. No abstract available.

PMID:
30846226
12.

SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.

Schlichtemeier SM, Nahm CB, Xue A, Gill AJ, Smith RC, Hugh TJ.

J Surg Res. 2019 Jun;238:127-136. doi: 10.1016/j.jss.2019.01.008. Epub 2019 Feb 13.

PMID:
30771682
13.

MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.

Gill P, Kim E, Chua TC, Clifton-Bligh RJ, Nahm CB, Mittal A, Gill AJ, Samra JS.

Endocr Pathol. 2019 Jun;30(2):128-133. doi: 10.1007/s12022-019-9570-y.

PMID:
30767148
14.

Management of post-pancreatectomy haemorrhage using resuscitative endovascular balloon occlusion of the aorta.

Singh G, Nahm CB, Jamieson NB, Chua TC, Wong S, Thoo C, Mittal A, Gill AJ, Samra JS.

Langenbecks Arch Surg. 2019 Mar;404(2):253-255. doi: 10.1007/s00423-019-01759-0. Epub 2019 Feb 13.

PMID:
30758668
15.

Revisiting the Significance of Prominent C Cells in the Thyroid.

Fuchs TL, Bell SE, Chou A, Gill AJ.

Endocr Pathol. 2019 Jun;30(2):113-117. doi: 10.1007/s12022-019-9567-6.

PMID:
30694510
16.

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory.

Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143. [Epub ahead of print]

PMID:
30570546
17.

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.

Pinho AV, Van Bulck M, Chantrill L, Arshi M, Sklyarova T, Herrmann D, Vennin C, Gallego-Ortega D, Mawson A, Giry-Laterriere M, Magenau A, Leuckx G, Baeyens L, Gill AJ, Phillips P, Timpson P, Biankin AV, Wu J, Rooman I.

Nat Commun. 2018 Nov 30;9(1):5083. doi: 10.1038/s41467-018-07497-z.

18.

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.

Parkin A, Man J, Chou A, Nagrial AM, Samra J, Gill AJ, Timpson P, Pajic M.

Diseases. 2018 Nov 13;6(4). pii: E103. doi: 10.3390/diseases6040103. Review.

19.

Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy.

Nahm CB, Lui I, Naidoo CS, Roseverne L, Alzaabi S, Maher R, Mann G, Blome S, Gill AJ, Samra JS, Mittal A.

HPB (Oxford). 2019 May;21(5):604-611. doi: 10.1016/j.hpb.2018.09.014. Epub 2018 Oct 28.

PMID:
30377050
20.

Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.

Nahm CB, Turchini J, Jamieson N, Moon E, Sioson L, Itchins M, Arena J, Colvin E, Howell VM, Pavlakis N, Clarke S, Samra JS, Gill AJ, Mittal A.

Eur J Surg Oncol. 2019 Feb;45(2):218-224. doi: 10.1016/j.ejso.2018.10.050. Epub 2018 Oct 11.

PMID:
30348604

Supplemental Content

Loading ...
Support Center